Ninety One (UK)’s Bristol-Myers Squibb BMY Stock Holding History

Ninety One (UK)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-218,355	Closed	-$13.2M	–	222
2020 Q3	$13.2M	Buy	+218,355	New	+$13.1M	0.05%	160

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ninety One (UK)'s BMY Position: Q4 2020 in Review

Ninety One (UK) sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 218,355 shares — an estimated $13.2M sold.

Ninety One (UK) first reported a position in BMY in Q3 2020 and held it in 1 quarter. The position peaked at $13.2M in Q3 2020. 2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

Ninety One (UK) reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
Ninety One (UK) sold 218,355 Bristol-Myers Squibb shares in Q4 2020, an estimated $13.2M.
Ninety One (UK) first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 1 quarter.
Ninety One (UK)'s Bristol-Myers Squibb position peaked at $13.2M in Q3 2020.
2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Ninety One (UK)'s 13F filing for Q4 2020, filed 5 Feb 2021.